Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatologists Respond to Prescription Opioid Analgesic Crisis

Larry Beresford  |  Issue: May 2017  |  May 16, 2017

If the pain is primarily driven by inflammation, the rheumatologist may be the best person to address it, so much the better if the underlying disease can be reduced. But that’s not always clear, Dr. Rapoport says. “Let’s say I have a patient with osteoarthritis, complaining of back pain. Signs of physical changes on the X-ray don’t always correlate to the patient’s reported pain. The benefits of opioids for the majority of these cases seem to fade rather rapidly, as substantiated in the recent literature, while side effects mount. This puts us in a difficult situation where we just don’t have good options. Sometimes, the only thing that works is opioids,” he says.

“Pain is one of the most common reasons why people visit rheumatologists,” notes Yvonne C. Lee, MD, rheumatologist at Brigham and Women’s Hospital in Boston. “We are very focused on inflammation, but that may not be the only, or even primary, cause of their pain.” A lot of attention goes into trying to figure out what is the cause, and for a lot of patients it can be multifactorial.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“We need to make sure we’re not abandoning our patients or missing diagnoses that could mimic rheumatologic conditions and explain the source of pain,” she says. “It’s also important to emphasize that we’ll be there for them—we’ll work with them to overcome the hurdles. We don’t want to say we can’t use opioids at all. It’s important to evaluate risks and benefits for each patient.”

The public has high expectations for medical care—some of that pushed by pharmacy companies’ direct-to-consumer advertising, Dr. Molloy says. “Patients believe they have the right to be pain free. Well, sometimes we can’t get rid of the patient’s pain. That makes for some very difficult conversations. Those of us who are willing to treat this pain, we can’t do it all. It takes me a lot of emotional effort and time to take care of chronic pain patients. They are very needy. I’m a rheumatologist. I don’t want to be a pain specialist, and I don’t want to advertise myself as a pain doctor,” he says.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Opioids are for when benefits are expected to outweigh risks, based on a thorough evaluation of pain & its causes, & a thorough discussion with the patient of the risk & benefit—including dangers from polypharmacy & from the concurrent use of alcohol.

Not all practicing rheumatologists want to get involved with these patients, Dr. Rapoport says. In fact, some rheumatologists were reluctant to share their experience with pain treatment for this article. “As a rheumatologist, treating our patients’ pain is a necessary part of our practice. But if you become known in the community as a doctor who writes pain prescriptions, you’ll end up getting a lot of office visits for reasons other than pain control,” he says.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:AnalgesicsConditionsDrug UpdatesPain SyndromesPractice Support Tagged with:AddictionanalgesicChronic painepidemicManagementopioidOverdosepatient careprescriptionRheumatic DiseaserheumatologistrheumatologyriskSafetyTreatment

Related Articles

    Speak Out Rheum: How Did We Go So Wrong with Opioid Prescribing?

    November 4, 2022

    I have been listening to The Fighter Pilot Podcast because my fantasy career would have been to fly a jet fighter plane (not even remotely possible, given my constitution). I learned that when an aircraft accident occurs, a mishap board is convened, not to assign blame but to try to learn what went wrong and…

    ah_designs / shutterstock.com

    The Perils of Pain Meds Revisited

    December 18, 2018

    More than 10 years ago, I wrote a commentary in The Rheumatologist, called “Perils of Pain Meds,” about the over-prescribing of opioid analgesics for common causes of chronic noncancer pain, which was a major contributor to the opioid epidemic.1 Since that time, although there has been a greater than 20% decrease in opioid prescribing, the…

    10 Tips for Opioid Prescribing

    December 1, 2014

    How to manage the risks when prescribing medications for patients in chronic pain

    urfin / shutterstock.com

    How to Improve Opioid Prescribing in an Outpatient Clinic

    October 18, 2019

    More than 72,000 Americans died from opioid overdoses in 2017, according to the National Institutes of Health.1 The impact of the opioid epidemic has affected many levels of patient care and, as a result, healthcare systems are responding to escalating death rates, new legislation and the possibility of compromised patient safety in a multitude of…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences